文献速递妇科

子宫切除术前聚维酮碘与氯己定阴道准备比较

Vaginal preparation with povidone-iodine or chlorhexidine before hysterectomy: a propensity score matched analysis.
PubMed 文献 · Am J Obstet Gynecol · 2021-08-30

这项回顾性倾向评分匹配分析纳入全州70家医院2017至2019年子宫切除术患者,比较聚维酮碘与氯己定阴道准备。匹配2935对后,聚维酮碘组感染性并发症(3.0% vs 4.3%;P=.01)、尿路感染(1.1% vs 1.7%;P=.03)和急诊就诊(7.9% vs 9.7%;P=.01)均低于氯己定组。

要点

  • 聚维酮碘阴道准备感染性并发症和急诊就诊率低于氯己定。
  • 绝对差异约1%,碘过敏时氯己定是合理替代。
  • 手术部位感染和再手术率差异无统计学意义。

核心结论

  • 子宫切除术前聚维酮碘阴道准备优于氯己定,感染性并发症和急诊就诊更少。
  • 绝对差异约1%,碘过敏时氯己定可作为合理替代。

主要发现

  • 匹配后聚维酮碘组感染性并发症3.0% vs 氯己定组4.3%(P=.01)。
  • 尿路感染1.1% vs 1.7%(P=.03),急诊就诊7.9% vs 9.7%(P=.01)。
  • 手术部位感染2.0% vs 2.7%(P=.07)和再手术1.6% vs 2.1%(P=.18)差异无统计学意义。

关键数值与推荐

  • 主要结局为术后30天内感染性并发症,包括尿路感染、手术部位感染(浅表、深部或器官间隙)或蜂窝织炎。
  • 匹配后两组人口学、合并症、术前抗生素选择、良恶性指征和手术方式无差异。

临床怎么用

  • 子宫切除术前阴道准备可优先选择聚维酮碘以降低感染性并发症和急诊就诊。
  • 碘过敏患者可选用氯己定作为替代。

局限性

  • 回顾性设计,原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antiseptic vaginal preparation is recommended before gynecologic surgery; however, there is a lack of data regarding the effectiveness of different agents. OBJECTIVE: To compare rates of postoperative infectious complications and hospital utilization with preoperative vaginal preparation using povidone-iodine or chlorhexidine before hysterectomy. STUDY DESIGN: This was a retrospective analysis of patients who underwent hysterectomy for gynecologic indications at 70 hospitals in a statewide surgical collaborative between January 2017 and December 2019. The primary outcome was postoperative infectious complications (including urinary tract infection, surgical site infections involving superficial, deep, or organ space tissues, or cellulitis) within 30 days of surgery. To adjust for confounding, propensity score matching, 1:1 without replacement and with a caliper of.005 was performed to create cohorts that had vaginal preparation with either povidone-iodine or chlorhexidine and did not differ in observable characteristics. We compared the rates of infectious morbidity and hospital utilization (emergency department visits, readmission, reoperation) in the matched cohorts. RESULTS: In the statewide collaborative, there were 18,184 patients who received povidone-iodine and 3018 who received chlorhexidine. After propensity score matching of 2935 pairs, the povidone-iodine and chlorhexidine groups did not differ in demographics, comorbidities, choice of preoperative antibiotics, benign vs malignant surgical indication, and surgical approach. Povidone-iodine was associated with a lower rate of infectious morbidity (3.0% vs 4.3%; P=.01), urinary tract infection (1.1% vs 1.7%; P=.03) and emergency department visits (7.9% vs 9.7%; P=.01) than with chlorhexidine. There were nonsignificant trends of lower rates of surgical site infection (2.0% vs 2.7%; P=.07) and reoperation (1.6% vs 2.1%; P=.18). CONCLUSION: This propensity score matched analysis provides evidence that povidone-iodine is preferable to chlorhexidine for vaginal preparation before hysterectomy because of lower rates of infectious morbidity and fewer emergency department visits. However, the absolute differences in infectious morbidity rates were approximately 1%, and in the event of an iodine allergy, chlorhexidine appears to be a reasonable alternative.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Skeith AE, Morgan DM, Schmidt PC, et al. Vaginal preparation with povidone-iodine or chlorhexidine before hysterectomy: a propensity score matched analysis. Am J Obstet Gynecol. 2021. PMID: 34473965. doi:10.1016/j.ajog.2021.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。